“Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s733. doi:10.25251/8r6ert44.